MannKind Corp
MNKD
#6155
Rank
HK$8.30 B
Marketcap
HK$25.82
Share price
-3.80%
Change (1 day)
-32.02%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): -HK$1.02

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -HK$1.02. In 2025 the company made an earnings per share (EPS) of HK$0.16 a decrease over its 2024 EPS that were of HK$0.78.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.02-748.67%
2025HK$0.16-80%
2024HK$0.78
2022-HK$2.676.25%
2021-HK$2.5128%
2020-HK$1.96-7.41%
2019-HK$2.12
2017-HK$8.71-188.1%
2016HK$9.89-128.31%
2015-HK$34.9274.51%
2014-HK$20.01-20.31%
2013-HK$25.11-32.63%
2012-HK$37.27-28.03%
2011-HK$51.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$32.00-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
HK$234.50-23,087.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$9.93-1,073.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$27.62-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-HK$52.58 5,053.85%๐Ÿ‡บ๐Ÿ‡ธ USA